Press Releases

DaVita Inc. , today announced results for the quarter ended March 31, 2002. Continental U.S. EBITDA excluding accounts receivable recoveries was $91.9 million for the quarter. For the 12 months...

DaVita Inc. announced today that on the afternoon of May 7 it received a subpoena from the Philadelphia office of the U.S. Department of Health and Human Services, Office of the Inspector General,...

In conjunction with DaVita's first quarter earnings release, you are invited to its conference call that will be broadcast live over the Internet on May 10, 2002, at 10 am Eastern Time hosted by...

DaVita Inc. today announced that it has extended its previously announced offer to purchase up to 20,000,000 of its common shares for ten business days, until 9:00 a.m., New York City time, on...

DaVita Inc. announced that it received a letter today from First Coast Service Options, Inc., the Medicare carrier for the Company's Florida laboratory, informing the Company of a change in the...

DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective April 25, 2002 at 5:01 PM Pacific Time. This pricing...

DaVita Inc. today announced that it has completed its tender offer for all of its outstanding 91/4% Senior Subordinated Notes due 2011. The note tender offer was originally announced on March 21,...

DaVita Inc. today revised the previously announced consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is...

DaVita Inc. today announced that in connection with its previously announced offer to purchase up to 24,000,000 of its common shares, it has increased the price at which it will purchase the...

DaVita Inc. today announced the consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is subject to the terms and...